Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through its Conditional and Time-Limited Approval pathway.
Scientists have shown that a single injection of self-amplifying RNA, delivered into skeletal muscle rather than the heart ...